Windlas Biotech has scheduled a conference call to discuss its financial performance for the quarter ended June 30, 2026. The event is set for August 11, 2026, at 11:30 AM IST, allowing investors and analysts to engage directly with management regarding the company's latest operational and financial outcomes. This disclosure is made pursuant to Clause 15 of Schedule III, Part A, Para A read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The conference call will be led by senior management, including Hitesh Windlass, Managing Director, and Komal Gupta, CEO and CFO. The company has provided dial-in details for domestic and international participants to ensure broad accessibility.

Conference Call Details

Participation Details

Participants can join the call via the following numbers:

• Primary Numbers: +91 22 6280 1256, +91 22 7115 8157
• International Toll Free:
  • Hong Kong: 800 964 448
  • Singapore: 800 101 2045
  • UK: 0 808 101 1573
  • USA: 1 866 746 2133

The conference call invite is also available on the company's website at www.windlas.com . For further information, investors may contact Ankit Jain or Manveer Sharma at Stellar IR.

Windlas Biotech shareholders approved a final dividend of ₹6.30 per equity share for the financial year ended March 31, 2026, and reappointed key board members at its 25th Annual General Meeting (AGM) held on July 23, 2026. The meeting, conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), saw strong shareholder engagement with 14,732,527 votes polled out of 20,636,229 shares held by eligible members, resulting in a 71.39% voting participation rate. All ordinary and special resolutions were passed with requisite majority, reflecting unified support for the company’s financial and governance decisions.

The AGM agenda included the adoption of audited standalone and consolidated financial statements for FY26, alongside the declaration of the final dividend. Shareholders also ratified the remuneration of the Cost Auditor. The voting process was scrutinized by Mr. Sandeep Joshi of M/s Sandeep Joshi & Associates, Practicing Company Secretary (Membership No. ACS-42945), who submitted his consolidated report on July 24, 2026, under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice for the AGM was dispatched on July 1, 2026, to 45,596 registered members, with remote e-voting open from July 20 to July 22, 2026.

Board Reappointments and New Appointment

Shareholders reappointed Hitesh Windlass, Managing Director (DIN: 02030941), and Prachi Jain Windlass, Director (DIN: 06661073), both of whom were liable to retire by rotation but offered themselves for re-appointment. Both resolutions received 100% support from the votes polled. Additionally, the company passed a special resolution to appoint Dr. Tarashree Singhal (DIN: 11697518) as an Independent Director, which also secured unanimous approval. These appointments ensure continuity in leadership while strengthening the independent oversight on the Board.

Voting Participation Analysis

The high voting turnout underscores active shareholder involvement in corporate governance matters. Promoter and Promoter Group entities held 13,065,352 shares and voted 13,065,349 shares, representing 100% participation within their category. Public institutional investors held 2,412,429 shares and cast 1,522,146 votes, yielding a 63.10% participation rate. Public non-institutional shareholders held 5,158,448 shares and cast 145,032 votes, corresponding to a 2.81% participation rate. The disparity in participation rates between promoter/institutional holders and retail non-institutional holders is typical in Indian listed companies, where large block holders engage more consistently in e-voting processes. The cut-off date for determining voting entitlement was July 16, 2026.